Initial Statement of Beneficial Ownership (3)
05 March 2021 - 9:46AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Simon Barry J. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/3/2021
|
3. Issuer Name and Ticker or Trading Symbol
Viracta Therapeutics, Inc. [VIRX]
|
(Last)
(First)
(Middle)
C/O VIRACTA THERAPEUTICS, INC., 2533 S COAST HWY 101, SUITE 210 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Street)
CARDIFF, CA 92007
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) | (1) | 12/15/2028 | Common Stock | 11190 | $0.90 | D | |
Explanation of Responses: |
(1) | One forty-eighth (1/48th) of the Shares subject to the Option shall vest on the one (1) month anniversary of December 15, 2018 (the "Vesting
Commencement Date"), and one forty-eighth (1/48th) of the Shares subject to the Option shall vest each month thereafter on the same day of the
month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person
continuing to be a Service Provider (as defined in the Viracta Subsidiary, Inc. 2016 Equity Incentive Plan) through each such date. |
Remarks: Exhibit 24: Power of Attorney |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Simon Barry J. C/O VIRACTA THERAPEUTICS, INC. 2533 S COAST HWY 101, SUITE 210 CARDIFF, CA 92007 | X |
|
|
|
Signatures
|
/s/ Michael Mueller, as Attorney-in-Fact | | 3/4/2021 |
**Signature of Reporting Person | Date |
Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From Apr 2024 to May 2024
Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From May 2023 to May 2024